These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Regulation of plasma triglycerides in insulin resistance and diabetes. Ginsberg HN; Zhang YL; Hernandez-Ono A Arch Med Res; 2005; 36(3):232-40. PubMed ID: 15925013 [TBL] [Abstract][Full Text] [Related]
47. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults. Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665 [TBL] [Abstract][Full Text] [Related]
48. [Lipid metabolism abnormalities in Chronic Kidney Disease]. Bianchi S; Baronti A; Cominotto R; Bigazzi R G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960010 [TBL] [Abstract][Full Text] [Related]
49. Lipid and lipoprotein dysregulation in insulin resistant states. Avramoglu RK; Basciano H; Adeli K Clin Chim Acta; 2006 Jun; 368(1-2):1-19. PubMed ID: 16480697 [TBL] [Abstract][Full Text] [Related]
50. Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins. Broedl UC; Maugeais C; Millar JS; Jin W; Moore RE; Fuki IV; Marchadier D; Glick JM; Rader DJ Circ Res; 2004 Jun; 94(12):1554-61. PubMed ID: 15117821 [TBL] [Abstract][Full Text] [Related]
51. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Adiels M; Olofsson SO; Taskinen MR; Borén J Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1225-36. PubMed ID: 18565848 [TBL] [Abstract][Full Text] [Related]
52. Apolipoprotein A-I complexed with phospholipid promotes hepatic lipoprotein and apolipoprotein secretion in the perfused hamster liver. Song W; Chen J; Redinger RN J Investig Med; 1998 Dec; 46(9):460-9. PubMed ID: 9861782 [TBL] [Abstract][Full Text] [Related]
53. Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effects of nutritional interventions. Barrett PH; Watts GF Curr Opin Lipidol; 2003 Feb; 14(1):61-8. PubMed ID: 12544663 [TBL] [Abstract][Full Text] [Related]
54. Lipoprotein Particles Interact with Membranes and Transfer Their Cargo without Receptors. Plochberger B; Sych T; Weber F; Novacek J; Axmann M; Stangl H; Sezgin E Biochemistry; 2020 Nov; 59(45):4421-4428. PubMed ID: 33147967 [TBL] [Abstract][Full Text] [Related]
55. Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans. Adiels M; Mardinoglu A; Taskinen MR; Borén J Front Physiol; 2015; 6():342. PubMed ID: 26635628 [TBL] [Abstract][Full Text] [Related]
57. Kinetic measurement techniques in the evaluation of lipid metabolism. Henderson GC Curr Drug Discov Technol; 2013 Sep; 10(3):209-23. PubMed ID: 23521572 [TBL] [Abstract][Full Text] [Related]
58. Lipoprotein metabolism: more than the sum of its parts. Packard CJ; Howard BV Curr Opin Lipidol; 1995 Jun; 6(3):115-6. PubMed ID: 7647998 [No Abstract] [Full Text] [Related]
59. New Insights Into the Regulation of Lipoprotein Metabolism by PCSK9: Lessons From Stable Isotope Tracer Studies in Human Subjects. Ying Q; Chan DC; Watts GF Front Physiol; 2021; 12():603910. PubMed ID: 33643062 [TBL] [Abstract][Full Text] [Related]
60. Hepatic VLDL secretion: DGAT1 determines particle size but not particle number, which can be supported entirely by DGAT2. Irshad Z; Chmel N; Adya R; Zammit VA J Lipid Res; 2019 Jan; 60(1):111-120. PubMed ID: 30397187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]